You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Part (iv) Estimated trends of problem stimulant use
Country | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | Drug use | method |
---|
Czech Republic | | | | | 2.82 | 2.69 | PSU | CM |
Spain | 2.42 | 5.22 | | | | | PSU | OT |
Finland | 4.5 | 5.2 | | | 5.86 | | PSU | CR |
Italy | | | | | 3.7 | 4.08 | PSU | MI |
Slovakia | | | | | 2.1 | 2.2 | PSU | OT |
Notes:
Time-series are combined where methods are similar over the time span. In some countries data are insufficient to report. |
Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. |
For more details see Tables PDU-1, PDU-2 and PDU-3 in the Statistical bulletin 2008. |
See also ‘General notes for interpreting data’ on the Explanatory notes and help page |
See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich. | Sources:
Reitox national focal points |
(see the help page for information about formats etc.)